Ultrasensitive Circulating Tumor DNA MRD Status Predicts Treatment Failure & Complements PET/CT throughout Treatment for Early and Advanced Stage Classic Hodgkin Lymphoma
Authors
Jan Boegeholz,
Cédric RossiJordan Goldstein,
Stefan Alig,
Andrea Garofalo,
Mohammad Esfahani,
Joseph Schroers‐Martin,
Chih Liu,
Mari Olsen,
Xiaoman Kang,
Feng Tian,
David Kurtz,
Marc André,
Luc‐Matthieu Fornecker,
Olivier Casasnovas,
Maximilian Diehn,
Hervé Ghesquières,
Ash Alizadeh +16 authors
,
Jack Goldstein Tip Tip